This journal publishes research on antibody-drug conjugates (ADCs) as a therapeutic strategy across various cancer types, including breast cancer, gastrointestinal malignancies, and lung cancer (small cell and non-small cell). The articles discuss the development, targets, challenges, and clinical applications of ADCs, with a focus on improving targeted delivery of cytotoxic payloads and enhancing patient outcomes.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Cancer ResearchQ1
OncologyQ1
Subject Classification
Web of Science Categories
Oncology
Scopus Categories
Cancer ResearchOncology
Research Topics (OpenAlex)
Lymphoma Diagnosis and TreatmentBreast Cancer Treatment StudiesGlobal Cancer Incidence and ScreeningSarcoma Diagnosis and TreatmentHead and Neck Cancer StudiesLung Cancer Treatments and MutationsAcute Lymphoblastic Leukemia researchCancer survivorship and careProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research